
Pantorav 40 Injection
Marketer
Ravic Healthcare
Salt Composition
Pantoprazole (40mg)
Overview Pantorav 40 Injection
Gastric acid secretion is diminished by the intravenous administration of Pantozol 40 Injection. This medication effectively manages stomach and intestinal disorders stemming from excess acidity, including conditions like gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome. It alleviates symptoms and facilitates healing. Prophylactic use is indicated for critically ill patients to prevent stress ulcers and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injectable medication, administered by a healthcare professional, is reserved for patients where intravenous therapy is deemed clinically preferable to oral administration. Dosage is individualized based on the patient's condition and response, with treatment duration determined by the physician. Consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Dietary modifications, such as frequent, smaller meals, and avoidance of caffeine, spicy foods, and fatty foods, may enhance treatment efficacy. Commonly reported side effects, often mild, include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal discomfort, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Extended use (over one year) may elevate the risk of fractures, particularly at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. This medication is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating women should seek medical counsel before use. Alcohol consumption should be avoided due to its acid-stimulating properties. Operation of machinery or driving should be avoided if drowsiness or dizziness occurs.
Uses of Pantorav 40 Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantorav 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Pantorav 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantorav 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pantorav 40 Injection works:
Acid reflux and indigestion find relief with Pantorav 40 Injection, a proton pump inhibitor that lessens stomach acid production.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Pantorav 40 Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Pantorav 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Pantorav 40 Injection appear compatible. Available human data indicates minimal infant risk associated with this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Pantorav 40 Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pantorav 40 Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with severe hepatic impairment should use Pantorav 40 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Pantorav 40 Injection :
Should you forget a scheduled Pantorav 40 Injection, seek your physician's advice.
Facts to Know About Pantorav 40 Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
